Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment.

[1]  K. Verba,et al.  Antibody discovery identifies regulatory mechanisms of protein arginine deiminase 4 , 2024, Nature chemical biology.

[2]  Xiao-Xue Kang,et al.  Inflammation-Responsive Nanoagents for Activatable Photoacoustic Molecular Imaging and Tandem Therapies in Rheumatoid Arthritis. , 2024, ACS nano.

[3]  Shaohui Deng,et al.  pH and ROS Dual-Sensitive Nanocarriers for the Targeted Co-Delivery and On-Demand Sequential Release of Tofacitinib and Glucosamine for Synergistic Rheumatoid Arthritis Treatment. , 2024, Small.

[4]  Danqing Huang,et al.  Biomimetic nanoparticles with cell-membrane camouflage for rheumatoid arthritis , 2024, Matter.

[5]  Xiaoxuan Zhang,et al.  CXCR4‐Expressing Mesenchymal Stem Cells Derived Nanovesicles for Rheumatoid Arthritis Treatment , 2023, Advanced healthcare materials.

[6]  Xiaolin Wang,et al.  Neutrophil-Mimetic, ROS Responsive, and Oxygen Generating Nanovesicles for Targeted Interventions of Refractory Rheumatoid Arthritis. , 2023, Small.

[7]  Jinwei Xie,et al.  Ingenious Synergy of a Pathology-Specific Biomimetic Multifunctional Nanoplatform for Targeted Therapy in Rheumatoid Arthritis. , 2023, Small.

[8]  Youngmee Jung,et al.  Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model. , 2023, Nature nanotechnology.

[9]  Zhengwei Cai,et al.  Reprogramming macrophages via immune cell mobilized hydrogel microspheres for osteoarthritis treatments , 2023, Bioactive materials.

[10]  Qingqi Meng,et al.  Pioglitazone-Loaded Cartilage-Targeted Nanomicelles (Pio@C-HA-DOs) for Osteoarthritis Treatment , 2023, International journal of nanomedicine.

[11]  Wei Wei,et al.  A Targeted Exosome Therapeutic Confers Both CfDNA Scavenging and Macrophage Polarization for Ameliorating Rheumatoid Arthritis , 2023, Advanced materials.

[12]  Wenxiang Cheng,et al.  Genetically Engineered Biomimetic Nanoparticles for Targeted Delivery of mRNA to Treat Rheumatoid Arthritis , 2023, Small methods.

[13]  Xun Sun,et al.  Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms , 2023, Signal transduction and targeted therapy.

[14]  Lichen Yin,et al.  Macrophage Membrane‐Reversibly Cloaked Nanotherapeutics for the Anti‐Inflammatory and Antioxidant Treatment of Rheumatoid Arthritis , 2023, Small methods.

[15]  F. Chen,et al.  A Dual-Targeted Metal-Organic Framework Based Nanoplatform for the Treatment of Rheumatoid Arthritis by Restoring the Macrophage Niche. , 2023, ACS nano.

[16]  Liangjing Lu,et al.  A biomimetic adipocyte mesenchymal stem cell membrane-encapsulated drug delivery system for the treatment of rheumatoid arthritis , 2023, Nano Research.

[17]  Jiulong Zhang,et al.  Nanoparticle-inhibited neutrophil elastase prevents neutrophil extracellular trap and alleviates rheumatoid arthritis in C57BL/6 mice , 2023, Nano Today.

[18]  Ke Wang,et al.  Hyaluronic acid-based M1 macrophage targeting and environmental responsive drug releasing nanoparticle for enhanced treatment of rheumatoid arthritis. , 2023, Carbohydrate polymers.

[19]  T. Hou,et al.  Glucocorticoid-loaded pH/ROS Dual-Responsive Nanoparticles Alleviate Joint Destruction by Downregulating the NF-κB Signaling Pathway. , 2023, Acta biomaterialia.

[20]  Xiaoqing Hu,et al.  Bioinspired Mild Photothermal Effect-Reinforced Multifunctional Fiber Scaffolds Promote Bone Regeneration. , 2023, ACS nano.

[21]  Jie Tian,et al.  Exosome inspired photo-triggered gelation hydrogel composite on modulating immune pathogenesis for treating rheumatoid arthritis , 2023, Journal of Nanobiotechnology.

[22]  Yan Hu,et al.  Redox Homeostasis Strategy for Inflammatory Macrophage Reprogramming in Rheumatoid Arthritis Based on Ceria Oxide Nanozyme-Complexed Biopolymeric Micelles. , 2023, ACS nano.

[23]  Yinhong Song,et al.  Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis , 2023, Journal of Nanobiotechnology.

[24]  Qi Guo,et al.  Ultrasound-Remote Selected Activation Mitophagy for Precise Treatment of Rheumatoid Arthritis by Two-Dimensional Piezoelectric Nanosheets. , 2022, ACS nano.

[25]  Gang Liu,et al.  Regulatory Fibroblast‐Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid Arthritis , 2022, Advanced science.

[26]  Liang Song,et al.  Dual‐Triggered Near‐Infrared Persistent Luminescence Nanoprobe for Autofluorescence‐Free Imaging‐Guided Precise Therapy of Rheumatoid Arthritis , 2022, Advanced science.

[27]  Lu Liu,et al.  Antibody-Sheltered Immunological Nanonut (Ainut) for Rheumatoid Arthritis-Targeted Efficient Alleviation , 2022, SSRN Electronic Journal.

[28]  C. Zeng,et al.  Engineered Platelet Microparticle-Membrane Camouflaged Nanoparticles for Targeting the Golgi Apparatus of Synovial Fibroblasts to Attenuate Rheumatoid Arthritis. , 2022, ACS nano.

[29]  Qin Wang,et al.  Inflammation-responsive nanoparticles suppress lymphatic clearance for prolonged arthritis therapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Ji-Ho Park,et al.  Porous Silicon-Based Nanomedicine for Simultaneous Management of Joint Inflammation and Bone Erosion in Rheumatoid Arthritis. , 2022, ACS nano.

[31]  W. Cui,et al.  A Smart Nanoreactor Based on an O2-Economized Dual Energy Inhibition Strategy Armed with Dual Multi-stimuli-Responsive "Doorkeepers" for Enhanced CDT/PTT of Rheumatoid Arthritis. , 2022, ACS nano.

[32]  M. Kanekiyo,et al.  The synovial microenvironment suppresses chondrocyte hypertrophy and promotes articular chondrocyte differentiation , 2022, npj Regenerative Medicine.

[33]  Ranjeny Thomas,et al.  Global epidemiology of rheumatoid arthritis , 2022, Nature Reviews Rheumatology.

[34]  Huanhuan Luo,et al.  Nanoarchitectonics of Cartilage-Targeting Hydrogel Microspheres with Reactive Oxygen Species Responsiveness for the Repair of Osteoarthritis. , 2022, ACS applied materials & interfaces.

[35]  W. Cui,et al.  Injectable Amphipathic Artesunate Prodrug‐Hydrogel Microsphere as Gene/Drug Nano‐Microplex for Rheumatoid Arthritis Therapy , 2022, Advanced Functional Materials.

[36]  H. Takayanagi,et al.  Mechanisms of joint destruction in rheumatoid arthritis — immune cell–fibroblast–bone interactions , 2022, Nature Reviews Rheumatology.

[37]  Xiaomei Song,et al.  Sinomenium acutum: A Comprehensive Review of its Botany, Phytochemistry, Pharmacology and Clinical Application. , 2022, The American journal of Chinese medicine.

[38]  D. Linke,et al.  Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists , 2022, Journal of Nanobiotechnology.

[39]  S. Alivernini,et al.  Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission , 2022, Nature Reviews Rheumatology.

[40]  Bin Liu,et al.  Multifunctional nanoparticles of sinomenine hydrochloride for treat-to-target therapy of rheumatoid arthritis via modulation of proinflammatory cytokines. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Jie-Young Song,et al.  TNF-α Induces Mitophagy in Rheumatoid Arthritis Synovial Fibroblasts, and Mitophagy Inhibition Alleviates Synovitis in Collagen Antibody-Induced Arthritis , 2022, International journal of molecular sciences.

[42]  Fang Wang,et al.  Nano Silver-Induced Toxicity and Associated Mechanisms , 2022, International journal of nanomedicine.

[43]  D. Peng,et al.  Emerging nanotherapeutics alleviating rheumatoid arthritis by readjusting the seeds and soils. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[44]  Ning Gu,et al.  Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment , 2022, Bioactive materials.

[45]  Changhai Ding,et al.  Highly effective rheumatoid arthritis therapy by peptide-promoted nanomodification of mesenchymal stem cells. , 2022, Biomaterials.

[46]  B. Klumperman,et al.  Macrophage-Targeted Hydroxychloroquine Nanotherapeutics for Rheumatoid Arthritis Therapy. , 2022, ACS applied materials & interfaces.

[47]  Yu Ma,et al.  Nanoengineered therapy aiming at the etiology of rheumatoid arthritis , 2022, Nano Today.

[48]  K. Ai,et al.  Rheumatoid arthritis microenvironment insights into treatment effect of nanomaterials , 2022, Nano Today.

[49]  Shuoxing Jiang,et al.  DNA origami as a nanomedicine for targeted rheumatoid arthritis therapy through reactive oxygen species and nitric oxide scavenging , 2022, bioRxiv.

[50]  Kecheng Zhang,et al.  Recent Advances in Osteoclast Biological Behavior , 2021, Frontiers in Cell and Developmental Biology.

[51]  Chunhong Li,et al.  M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[52]  Cheng Xiao,et al.  Dysfunctions, Molecular Mechanisms, and Therapeutic Strategies of Regulatory T Cells in Rheumatoid Arthritis , 2021, Frontiers in Pharmacology.

[53]  Jian-xin Liu,et al.  Nanomaterials Manipulate Macrophages for Rheumatoid Arthritis Treatment , 2021, Frontiers in Pharmacology.

[54]  Jinmin Zhao,et al.  Cartilage-targeting poly(ethylene glycol) (PEG)-formononetin (FMN) nanodrug for the treatment of osteoarthritis , 2021, Journal of Nanobiotechnology.

[55]  D. Jo,et al.  Metabolically engineered stem cell–derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis , 2021, Science Advances.

[56]  Man Li,et al.  Shield and sword nano-soldiers ameliorate rheumatoid arthritis by multi-stage manipulation of neutrophils. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[57]  Jiyu Fang,et al.  Dual-Stimuli Responsive Polymeric Micelles for the Effective Treatment of Rheumatoid Arthritis. , 2021, ACS applied materials & interfaces.

[58]  Xun Sun,et al.  Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis , 2021, Nature Communications.

[59]  C. Fan,et al.  Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations , 2021, Advanced materials.

[60]  Jiyu Fang,et al.  Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies , 2021, Acta pharmaceutica Sinica. B.

[61]  P. Ji,et al.  An oligopeptide/aptamer-conjugated dendrimer-based nanocarrier for dual-targeting delivery to bone. , 2021, Journal of materials chemistry. B.

[62]  Liang Liu,et al.  Suppression of macrophage migration by down-regulating Src/FAK/P130Cas activation contributed to the anti-inflammatory activity of sinomenine. , 2021, Pharmacological research.

[63]  S. Gay,et al.  Location, location, location: how the tissue microenvironment affects inflammation in RA , 2021, Nature Reviews Rheumatology.

[64]  Chuanglong He,et al.  Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy , 2021, Bioactive materials.

[65]  Zhirong Zhong,et al.  Treatment of Rheumatoid Arthritis by Serum Albumin Nanoparticles Coated with Mannose to Target Neutrophils. , 2020, ACS applied materials & interfaces.

[66]  F. Guilak,et al.  Immunoengineering the Next Generation of Arthritis Therapies , 2020, Acta biomaterialia.

[67]  C. Weyand,et al.  The immunology of rheumatoid arthritis , 2020, Nature Immunology.

[68]  Yong-Hee Kim,et al.  RNA interference-mediated suppression of TNF-α converting enzyme as an alternative anti-TNF-α therapy for rheumatoid arthritis. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[69]  Jin Li,et al.  Targeted Combination of Antioxidative and Anti-Inflammatory Therapy of Rheumatoid Arthritis using Multifunctional Dendrimer-Entrapped Gold Nanoparticles as a Platform. , 2020, Small.

[70]  Peng Liu,et al.  Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization. , 2020, Biomaterials.

[71]  Yanni He,et al.  Near-infrared fluorescence imaging-guided focused ultrasound-mediated therapy against Rheumatoid Arthritis by MTX-ICG-loaded iRGD-modified echogenic liposomes , 2020, Theranostics.

[72]  Zhirong Zhang,et al.  Palmitic acid-modified bovine serum albumin nanoparticles target scavenger receptor-A on activated macrophages to treat rheumatoid arthritis. , 2020, Biomaterials.

[73]  H. L. Wright,et al.  Rheumatoid Arthritis Synovial Fluid Neutrophils Drive Inflammation Through Production of Chemokines, Reactive Oxygen Species, and Neutrophil Extracellular Traps , 2020, Frontiers in Immunology.

[74]  Zhirong Zhong,et al.  Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis , 2020, Journal of Nanobiotechnology.

[75]  Christopher V. Barback,et al.  Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal , 2020, Science Advances.

[76]  M. Busquets,et al.  Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications. , 2020, Drug discovery today.

[77]  G. Firestein,et al.  Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes , 2020, Nature Reviews Rheumatology.

[78]  J. Ji,et al.  Sialic acid-modified chitosan oligosaccharide-based biphasic calcium phosphate promote synergetic bone formation in rheumatoid arthritis therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[79]  P. Naik,et al.  PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets , 2020, Nature Reviews Rheumatology.

[80]  Chao Yang,et al.  In situ construction of ligand nano-network to integrin αvβ3 for angiogenesis inhibition , 2020 .

[81]  Salman Khan,et al.  Surfactant Free, Self-Assembled Nanomicelles-Based Transdermal Hydrogel for Safe and Targeted Delivery of Methotrexate against Rheumatoid Arthritis. , 2020, ACS nano.

[82]  Liang Liu,et al.  ROS-Responsive Berberine Polymeric Micelles Effectively Suppressed the Inflammation of Rheumatoid Arthritis by Targeting Mitochondria , 2020, Nano-micro letters.

[83]  J. Ge,et al.  M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway. , 2020, Journal of molecular and cellular cardiology.

[84]  Jing Lv,et al.  Recent Advances in Nanotheranostics for Treat‐to‐Target of Rheumatoid Arthritis , 2020, Advanced healthcare materials.

[85]  Raghu Kalluri,et al.  The biology, function, and biomedical applications of exosomes , 2020, Science.

[86]  Gang Liu,et al.  TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[87]  Qin Liu,et al.  Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway. , 2019, Biomaterials.

[88]  Yongzhong Du,et al.  Sinomenine hydrochloride loaded thermosensitive liposomes combined with microwave hyperthermia for the treatment of rheumatoid arthritis. , 2019, International journal of pharmaceutics.

[89]  A. Salama,et al.  Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN. , 2019, Journal of the American Society of Nephrology : JASN.

[90]  Gangliang Huang,et al.  Application of glycosylation in targeted drug delivery. , 2019, European journal of medicinal chemistry.

[91]  M. McGee-Lawrence,et al.  Stromal cell-derived factor-1 (CXCL12) and its role in bone and muscle biology. , 2019, Cytokine.

[92]  M. Cutolo,et al.  Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. , 2019, Autoimmunity reviews.

[93]  I. Chronakis,et al.  Citrullinated peptide epitope targets therapeutic nanoparticles to human neutrophils. , 2019, Bioconjugate chemistry.

[94]  J. Javůrek,et al.  Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis. , 2019, Journal of autoimmunity.

[95]  D. Wagner,et al.  Extracellular DNA NET-Works With Dire Consequences for Health. , 2019, Circulation research.

[96]  Haibin Zhang,et al.  The Function of PPARγ/AMPK/SIRT-1 Pathway in Inflammatory Response of Human Articular Chondrocytes Stimulated by Advanced Glycation End Products. , 2019, Biological & pharmaceutical bulletin.

[97]  M. Dougados,et al.  Novel DMARD monotherapy in rheumatoid arthritis , 2019, The Lancet.

[98]  S. Raychaudhuri,et al.  Distinct fibroblast subsets drive inflammation and damage in arthritis , 2019, Nature.

[99]  T. Lammers,et al.  Combining Nanomedicine and Immunotherapy. , 2019, Accounts of chemical research.

[100]  Erpan Ahat,et al.  Golgi Structure and Function in Health, Stress, and Diseases , 2019, Results and problems in cell differentiation.

[101]  Piyush Gondaliya,et al.  Nanogold-core multifunctional dendrimer for pulsatile chemo-, photothermal- and photodynamic- therapy of rheumatoid arthritis. , 2019, Journal of colloid and interface science.

[102]  R. Baumgartner,et al.  Human serum albumin-based probes for molecular targeting of macrophage scavenger receptors , 2019, International journal of nanomedicine.

[103]  Benjamin Friedman,et al.  Methotrexate mechanism in treatment of rheumatoid arthritis. , 2019, Joint, bone, spine : revue du rhumatisme.

[104]  I. Fraser,et al.  NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration , 2019, Front. Immunol..

[105]  Rakeshchandra R. Meka,et al.  Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy. , 2019, Nanomedicine.

[106]  Jae-Sung Kim,et al.  Formononetin Antagonizes the Interleukin-1β-Induced Catabolic Effects Through Suppressing Inflammation in Primary Rat Chondrocytes , 2019, Inflammation.

[107]  M. Kaplan,et al.  Neutrophils in Rheumatoid Arthritis: Breaking Immune Tolerance and Fueling Disease. , 2019, Trends in molecular medicine.

[108]  Yun Bai,et al.  Redox control of chondrocyte differentiation and chondrogenesis , 2019, Free radical biology & medicine.

[109]  Xu Chen,et al.  Targeted hexagonal Pd nanosheet combination therapy for rheumatoid arthritis via the photothermal controlled release of MTX. , 2019, Journal of materials chemistry. B.

[110]  Wentao Dai,et al.  Route to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles. , 2018, Nano letters.

[111]  C. Evans.  Catering to chondrocytes , 2018, Science Translational Medicine.

[112]  G. Schett,et al.  Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis , 2018, Nature Reviews Rheumatology.

[113]  J. Smolen,et al.  Diagnosis and Management of Rheumatoid Arthritis: A Review , 2018, JAMA.

[114]  Jong Oh Kim,et al.  Prussian blue nanoparticles: Synthesis, surface modification, and application in cancer treatment , 2018, International journal of pharmaceutics.

[115]  E. Lubberts,et al.  1,25(OH)2D3 and dexamethasone additively suppress synovial fibroblast activation by CCR6+ T helper memory cells and enhance the effect of tumor necrosis factor alpha blockade , 2018, Arthritis Research & Therapy.

[116]  Ronnie H. Fang,et al.  Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis , 2018, Nature Nanotechnology.

[117]  H. Griffiths,et al.  The dual role of Reactive Oxygen Species in autoimmune and inflammatory diseases: evidence from preclinical models , 2018, Free radical biology & medicine.

[118]  M. Whiteman,et al.  Oxidative stress in autoimmune rheumatic diseases , 2018, Free radical biology & medicine.

[119]  Xu Chen,et al.  Polypeptide nano-Se targeting inflammation and theranostic rheumatoid arthritis by anti-angiogenic and NO activating AMPKα signaling pathway. , 2018, Journal of materials chemistry. B.

[120]  J. Varshosaz,et al.  Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment , 2018, Artificial cells, nanomedicine, and biotechnology.

[121]  C. Martins,et al.  Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells , 2018, Nature Communications.

[122]  Jian You,et al.  Endogenous sialic acid-engineered micelles: a multifunctional platform for on-demand methotrexate delivery and bone repair of rheumatoid arthritis. , 2018, Nanoscale.

[123]  Chang-Long Zhou,et al.  Synovial fibroblast‐targeting liposomes encapsulating an NF‐κB‐blocking peptide ameliorates zymosan‐induced synovial inflammation , 2018, Journal of cellular and molecular medicine.

[124]  Zhirong Zhong,et al.  Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy , 2018, Drug delivery.

[125]  J. Ochando,et al.  T follicular helper cells: a potential therapeutic target in follicular lymphoma , 2017, Oncotarget.

[126]  H. Katsumi,et al.  Development of PEGylated carboxylic acid-modified polyamidoamine dendrimers as bone-targeting carriers for the treatment of bone diseases. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[127]  M. A. Rosillo,et al.  Extra-virgin olive oil phenols hydroxytyrosol and hydroxytyrosol acetate, down-regulate the production of mediators involved in joint erosion in human synovial cells , 2017 .

[128]  H. Shim,et al.  Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A 2-Year Follow-up Study , 2017, The American journal of sports medicine.

[129]  Kwangmeyung Kim,et al.  Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis. , 2017, Biomaterials.

[130]  Hanmei Xu,et al.  Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis , 2017, International journal of molecular sciences.

[131]  M. Guma,et al.  Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis , 2017, Arthritis Research & Therapy.

[132]  Xuesi Chen,et al.  Scavenger Receptor-Mediated Targeted Treatment of Collagen-Induced Arthritis by Dextran Sulfate-Methotrexate Prodrug , 2017, Theranostics.

[133]  C. C. Guarda,et al.  Influence of Hydroxyurea on Neutrophil Microparticles: A SCA Model , 2016 .

[134]  R. Califf,et al.  Clarifying Stem-Cell Therapy's Benefits and Risks. , 2016, The New England journal of medicine.

[135]  Yong-Hee Kim,et al.  RNAi-mediated silencing of TNF-α converting enzyme to down-regulate soluble TNF-α production for treatment of acute and chronic colitis. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[136]  A. Mantovani,et al.  Macrophage heterogeneity in the context of rheumatoid arthritis , 2016, Nature Reviews Rheumatology.

[137]  Bálint Szabó,et al.  Complement MASP-1 enhances adhesion between endothelial cells and neutrophils by up-regulating E-selectin expression. , 2016, Molecular immunology.

[138]  Bin Du,et al.  A photoelectrochemical biosensor for fibroblast-like synoviocyte cell using visible light-activated NCQDs sensitized-ZnO/CH3NH3PbI3 heterojunction. , 2016, Biosensors & bioelectronics.

[139]  V. Kuchroo,et al.  Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions. , 2015, Immunity.

[140]  J. Bueren,et al.  Human Adipose‐Derived Mesenchymal Stem Cells Modulate Experimental Autoimmune Arthritis by Modifying Early Adaptive T Cell Responses , 2015, Stem cells.

[141]  F. Dell’Accio,et al.  Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis , 2015, Science Translational Medicine.

[142]  J. Selbig,et al.  Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects , 2015, Scientific Reports.

[143]  Yifan Ma,et al.  Doxorubicin-loaded pH-sensitive dextran-retinal nanoparticles suppress tumor growth by inducing both apoptosis and cell senescence. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[144]  Alan Trounson,et al.  Stem Cell Therapies in Clinical Trials: Progress and Challenges. , 2015, Cell stem cell.

[145]  Xiaojuan He,et al.  A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts. , 2015, Biomaterials.

[146]  E. Peeva,et al.  Hormonal modulation of the immune system - A spotlight on the role of progestogens. , 2015, Autoimmunity reviews.

[147]  L. Norling,et al.  The resolution of inflammation: Principles and challenges. , 2015, Seminars in immunology.

[148]  A. Galeone,et al.  Negligible particle-specific toxicity mechanism of silver nanoparticles: the role of Ag+ ion release in the cytosol. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[149]  Robert J. Moots,et al.  The multifactorial role of neutrophils in rheumatoid arthritis , 2014, Nature Reviews Rheumatology.

[150]  Song Li,et al.  Polymeric Micelles: Nanocarriers for Cancer-Targeted Drug Delivery , 2014, AAPS PharmSciTech.

[151]  S. Schibeci,et al.  Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis. , 2014, Clinical immunology.

[152]  D. Chang,et al.  TACE-dependent amphiregulin release is induced by IL-1β and promotes cell invasion in fibroblast-like synoviocytes in rheumatoid arthritis. , 2014, Rheumatology.

[153]  Kwangmeyung Kim,et al.  Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging. , 2014, Carbohydrate polymers.

[154]  J. Buckland.  Experimental arthritis: iRHOM2—a new potential therapeutic target for inflammatory arthritis , 2013, Nature Reviews Rheumatology.

[155]  G. Watts,et al.  Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement. , 2011, Arthritis and rheumatism.

[156]  P. Tessier,et al.  Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption. , 2009, Blood.

[157]  J. Hubbell,et al.  Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. , 2008, Nature materials.

[158]  Y. Lyubchenko,et al.  Osteotropic Peptide that differentiates functional domains of the skeleton. , 2007, Bioconjugate chemistry.

[159]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[160]  Philip S Low,et al.  Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. , 2008, Accounts of chemical research.

[161]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.